“We think of open source as being a process for developing software. It’s also a process for developing cures.
As Gina Kolata notes at The New York Times, it’s working in the area of Alzheimer’s Disease.
In this case the National Institutes of Health acted as a broker among both public and private institutions, the idea being that resulting knowledge on biomarkers would be shared.”
Article
Dana Blankenhorn, ZDNet Healthcare, 16 August 2010
